Position in HIMS
as of Mar 31, 2026
· filed May 4, 2026
Position Value
$0
+$0 QoQ
Shares Held
0
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
6 quarters on record
Common Shares in HIMS Over Time
Shares Held
Position Value (USD)
Derivatives in HIMS
reported options exposure · as of Mar 31, 2026CallValue
$0
CallShares
0
PutValue
$12,325,212
PutShares
593,700
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026WOLVERINE ASSET MANAGEMENT LLC holds $2,458,736 across 5 Drug Manufacturers - Specialty & Generic names.
All Filings in HIMS
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $12,325,212 | 593,700 | Put | Defined | 2026-05-04 | |
| 2025-12-31 | $29,956,822 | 922,600 | Put | Defined | 2026-02-02 | |
| 2025-09-30 | $26,505,256 | 467,300 | Put | Defined | 2025-10-28 | |
| 2025-06-30 | $9,027,835 | 181,100 | Put | Defined | 2025-08-04 | |
| 2021-06-30 | $445,553 | 40,914 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $673,235 | 50,887 | Shares | Defined | 2021-05-13 | |
| No filing history on record for this holder in this stock. | ||||||